| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |